about
Prevalence of microcephaly in Europe: population based studyEUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associationsVariations in Multiple Birth Rates and Impact on Perinatal Outcomes in EuropeImproving Information on Maternal Medication Use by Linking Prescription Data to Congenital Anomaly Registers: A EUROmediCAT StudyGenetic and environmental influences on birth weight, birth length, head circumference, and gestational age by use of population-based parent-offspring data.Associations of adherence to the New Nordic Diet with risk of preeclampsia and preterm delivery in the Norwegian Mother and Child Cohort Study (MoBa)Perinatal mortality by gestational week and size at birth in singleton pregnancies at and beyond term: a nationwide population-based cohort studyValidity of pre-eclampsia registration in the medical birth registry of norway for women participating in the norwegian mother and child cohort study, 1999-2010.Varying gestational age patterns in cesarean delivery: an international comparison.Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review.Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report.Holt Oram syndrome: a registry-based study in Europe.Availability and access in modern obstetric care: a retrospective population-based study.Change in paternity, risk of placental abruption and confounding by birth interval: a population-based prospective cohort study in Norway, 1967-2009.Risk of fetal death with preeclampsia.Prevalence, prenatal diagnosis and clinical features of oculo-auriculo-vertebral spectrum: a registry-based study in EuropePopulation-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study.Preeclampsia in pregnancy and later use of antihypertensive drugs.In utero exposure to maternal tobacco smoke and subsequent obesity, hypertension, and gestational diabetes among women in the MoBa cohort.Pre-pregnant body mass index and recreational physical activity: effects on perinatal mortality in a prospective pregnancy cohort.Prescribing of Antidiabetic Medicines before, during and after Pregnancy: A Study in Seven European RegionsElective cesarean section or not? Maternal age and risk of adverse outcomes at term: a population-based registry study of low-risk primiparous women.Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.Epidemiology of hypospadias in Europe: a registry-based study.Long term trends in prevalence of neural tube defects in Europe: population based studyCardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study.Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening.Asthma medication prescribing before, during and after pregnancy: a study in seven European regions.Meckel-Gruber Syndrome: a population-based study on prevalence, prenatal diagnosis, clinical features, and survival in EuropeLamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies.Preconception Cardiovascular Risk Factor Differences Between Gestational Hypertension and Preeclampsia: Cohort Norway Study.Placental abruption and long-term maternal cardiovascular disease mortality: a population-based registry study in Norway and Sweden.Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy - a cohort linkage study.Long-term mortality in mothers with perinatal losses and risk modification by surviving children and attained education: a population-based cohort study.Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.Epidemiology of multiple congenital anomalies in Europe: a EUROCAT population-based registry study.Use of asthma medication during pregnancy and risk of specific congenital anomalies: A European case-malformed control study.Gastroschisis in Europe - A Case-malformed-Control Study of Medication and Maternal Illness during Pregnancy as Risk Factors.Gestational diabetes mellitus and interpregnancy weight change: A population-based cohort study.Mode of first delivery and severe maternal complications in the subsequent pregnancy.
P50
Q26970768-E2AF931F-7183-414B-8FF4-36181F97D22DQ28817912-BABA52F5-C63B-458A-9127-C002BED45D76Q29353624-1E6414EC-F359-485F-ADF5-24381E203C7AQ30979187-767FADD3-B17B-4AD3-A13F-5D2363EB07DEQ31101849-558DDBD8-FF3C-4651-BDA0-4F8EC9AE8905Q33620530-4452F3FA-1EE6-4014-904D-CA6BBC75E6AFQ33679972-FD5EB871-2BBC-4472-8F76-8DCAB9D90C0CQ34203506-AB1532D7-3222-486F-B8DB-2ED3F43001F2Q34256114-F6863FA6-C50F-4C5F-8D37-DFD9CD452B07Q34541036-BF499761-EE1C-4287-839E-3DC833BD7C0EQ34556168-3E050A90-B033-475D-A76A-73DA5313C7E8Q34576306-77703E93-6A61-42BF-8CDC-9A8B1792170CQ34617607-C6340F0A-A393-484C-8EF2-40864C0B6D29Q35074991-86E52F91-BB7A-4672-9B2A-CEDDE01A5975Q35141743-C5E2575F-EB67-4A8A-B5BA-352500814FF4Q35150515-35A3164E-0EA7-44E1-AEEB-EEBA83FC41E0Q35320390-36387155-19F4-4136-A05A-E431BDC3F53CQ35798781-67138604-29DF-4EA2-956C-126CD0769D5AQ35807828-B67FDDFD-1D40-412B-83BF-E299A21D3BFCQ35912298-40B96141-BEE0-4B32-8FBE-69CB3DC4630DQ36021430-2D81DC4E-21A6-42C5-894E-72D51C8362ADQ36106318-69EEF797-0EE9-46CE-A194-146BADD515B6Q36209588-454F61FC-A7C2-4A59-8696-358970DF3C9DQ36304503-AE10A777-6393-4DF4-80AC-DABAEA3A3D0DQ36316162-11946092-CFEA-4E3A-874C-1A02DC3B79A9Q36428404-248A85D2-5D8E-41F8-9956-C99AD5A45AD1Q36466446-56B99EAF-CCF7-4AB0-BC86-868FB84CC73AQ36526636-9DD9682E-6CE0-43E5-97EF-33FE867B11FCQ36695145-1BB11A5D-EE7F-4136-8E28-11CB670E05E2Q36862763-B2D60B50-DC64-42F1-8A12-4695A0484E45Q36885556-E915DB9D-D202-4D46-8502-D4DF9A4CD095Q36990027-B2D9B091-E411-4A4F-9E93-5C58268042D2Q37375534-1746138A-2145-4F69-A9AF-E0B7D4AB3BC9Q37516715-C0C91B18-732E-4B96-AAF5-7E69D5C722C1Q37671906-6AFF75F6-45A9-412B-ABD8-20C63A997B0CQ38203855-159DD6A5-2691-469B-AD75-52F4E541E915Q38556554-C691F407-B1DB-470D-A5BB-1D4C4BF70EEBQ38608049-F5390BAB-3538-43AE-A7E4-5B81D25EB26EQ38649280-B1AE4CA7-751D-4AB3-9CBA-16137CC5C7EFQ38807011-15D4B101-8745-4DCD-98BD-6935F1EC8805
P50
description
Noors onderzoekster
@nl
norsk forsker
@nb
researcher ORCID ID = 0000-0003-2482-1690
@en
name
Kari Klungsøyr
@ast
Kari Klungsøyr
@en
Kari Klungsøyr
@es
Kari Klungsøyr
@ga
Kari Klungsøyr
@nb
Kari Klungsøyr
@nl
Kari Klungsøyr
@sl
Kari Klungsøyr
@sq
type
label
Kari Klungsøyr
@ast
Kari Klungsøyr
@en
Kari Klungsøyr
@es
Kari Klungsøyr
@ga
Kari Klungsøyr
@nb
Kari Klungsøyr
@nl
Kari Klungsøyr
@sl
Kari Klungsøyr
@sq
altLabel
Kari K Melve
@en
Kari K. Melve
@nb
Kari Klungsøyr Melve
@nb
Kari Melve
@nb
prefLabel
Kari Klungsøyr
@ast
Kari Klungsøyr
@en
Kari Klungsøyr
@es
Kari Klungsøyr
@ga
Kari Klungsøyr
@nb
Kari Klungsøyr
@nl
Kari Klungsøyr
@sl
Kari Klungsøyr
@sq
P106
P21
P27
P31
P496
0000-0003-2482-1690